Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy
Condition: Leukemia, Myeloid, Acute Interventions: Drug: Pevonedistat; Drug: Azacitidine Sponsors: PETHEMA Foundation; Millennium Pharmaceuticals, Inc.; Dynamic Science S.L. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials